Antimalarial Drugs Market to Grow Immensely at a CAGR of 4.60% From 2023 To 2032
According to Custom Market Insights (CMI), the global Antimalarial Drugs Market size was estimated at USD 877.59 million in 2023 and is anticipated to reach around USD 1202.21 million by 2032, recording a CAGR of roughly 4.6% between 2023 and 2032. The “World Malaria Report 2021” published by the World Health Organization (WHO) revealed that there were approximately 227 million cases and almost 603,000 deaths related to malaria in 2020. Such a high prevalence of malaria is expected to result in increased utilization of antimalarial treatments, thereby propelling the growth of the Antimalarial drugs market. Browse the full “ Anti-Malarial Drugs Market Size, Trends and Insights By Drug Class (Quinine, Chloroquine, Proguanil, Mefloquine, Pyrimethamine, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-Commerce & Other Distribution Channel), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and...